BioNTech is preparing to apply for vaccinations for children over 2 years old

German pharmaceutical firm BioNTech plans to request authorization of the coronavirus vaccine for children over the age of two this fall, in accordance to German public tv ZDF.

The corporate, which produces and distributes the coronavirus vaccine worldwide, along with the American pharmaceutical firm Pfizer, introduced that the outcomes of the exams they carried out on children may come till September.



The BioNTech-Pfizer vaccine grew to become the primary globally licensed for ages 16 and over on the finish of final yr, and the primary to obtain the inexperienced mild from the US and European Union for children ages 12 to 16 this Could.

In Germany, nevertheless, this method is not really useful by the Standing Vaccination Fee (Stiko) for all children aged 12 to 16 years, however solely for children with pre-existing diseases for whom coronavirus an infection could pose a selected threat.

German firm BioNTech and Pfizer introduced that they’ve progressively began exams in children underneath the age of 12 this yr, in accordance to age teams, so as to confirm the effectiveness of their vaccines in several teams and on the required doses.

The pharmaceutical firm additionally plans to examine the outcomes of its anti-coronavirus formulation in children aged 6 months to 2 years this yr.

You May Also Like:  Why is it important to eat foods rich in iron?

Vaccination continues in Turkey for these aged 18 and over.

#BioNTech #preparing #apply #vaccinations #children #years

Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

10 tips to reduce sugar in children’s diets

Skin diseases for which sunbathing can be beneficial